|
業務類別
|
Biotechnology |
|
業務概覽
|
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNScancers, including GBM. Its pipeline products are PRMT5 and CoREST. |
| 公司地址
| 201 Brookline Avenue, Suite 901, Boston, MA, USA, 02215 |
| 電話號碼
| +1 857 320-4900 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.tangotx.com |
| 員工數量
| 155 |
| Dr. Malte Peters, M.D. |
President, Chief Executive Officer and Director |
-- |
08/01/2026 |
| Ms. Daniella Beckman |
Chief Financial Officer |
美元 486.31K |
05/03/2026 |
| Ms. Julie Carretero |
Chief Human Resources Officer |
-- |
21/04/2025 |
| Dr. Adam Crystal, M.D.,PhD |
President, Research and Development |
美元 569.25K |
21/04/2025 |
|
|
| Mr. John B. Ketchum |
Independent Director |
05/03/2026 |
| Dr. Mace Rothenberg, M.D. |
Independent Director |
05/03/2026 |
| Dr. Malte Peters, M.D. |
President, Chief Executive Officer and Director |
08/01/2026 |
| Dr. Barbara L. Weber, M.D. |
Executive Chairman of the Board |
08/01/2026 |
| Mr. Sung H. Lee |
Independent Director |
05/01/2026 |
| Ms. Lesley Ann Calhoun |
Independent Director |
05/03/2026 |
| Mr. Kanishka Pothula |
Independent Director |
05/03/2026 |
| Mr. Alexis A. Borisy, A.M. |
Lead Independent Director |
08/01/2026 |
|
|
|
|
